Our Authors
Fran Boyle is a Medical Oncologist at North Sydney’s Mater Hospital, where she is Director of the Patricia Ritchie Centre for Cancer Care and Research, and Professor of Medical Oncology. She has been involved in research and teaching in communication in health care for the past 20 years, and is currently Director of the Pam McLean Centre in the Sydney Medical School. Understanding professional burnout, and its relationship to empathy, teamwork and communication, has been a focus for the Pam McLean team. The more so as they find themselves trying to be balanced during crazy times with COVID.2 Articles
Professor Diana Sarfati (MBChB, MPH, PhD, FNZCPHM) is National Director of Cancer Control and Chief Executive of Te Aho o Te Kahu, the Cancer Control Agency in New Zealand. Her role is to provide national leadership for, and oversight of cancer control, to provide policy advice to the Government, and to be accountable for ensuring progress towards the goals and outcomes in the New Zealand Cancer Action Plan. Previously Diana was Head of the Department of Public Health and Director of the Cancer and Chronic Conditions (C3) research group at University of Otago, Wellington. She has led a large body of research relating to disparities in cancer outcomes. This work has resulted in the identification of key patient and health system factors that influence cancer survival. It has been used extensively by health policy makers, clinicians and other researchers to develop policies and practices that aim to reduce inequities in cancer outcomes.2 Articles
Emeritus Professor Ian Maddocks is an eminent palliative care specialist and a passionate advocate for world peace. A specialist physician in the Australian Administration of Papua New Guinea for 14 years, he became Foundation Dean of the Faculty of Medicine at the University of Papua New Guinea in 1971. Since 1982 he has worked with medical groups seeking to eliminate nuclear weapons. Ian was President of the Medical Association for Prevention of War when it received an Australian Peace Medal, and Vice-President of International Physicians for Prevention of Nuclear War when it received the Nobel Prize for Peace in 1985. Since 1980 he has advocated improved care for the dying, and was first Chair of Palliative Care at Flinders University, first President of the Australian Association for Hospice and Palliative Care and first President of the Australian and New Zealand Society for Palliative Medicine. Recipient of the inaugural Bethlehem Griffiths Medal for research in palliative care, Ian is recognised internationally for his work in palliative care, tropical and preventative medicine. Now Emeritus Professor at Flinders University, he continues daily care for the terminally ill.2 Articles
BXTAccelyon (BXTA) is the leading low-dose rate brachytherapy (LDR-B) partner to hospitals and clinics worldwide, and distribution partner for the PrecisionPoint™ freehand transperineal prostate biopsy system.2 Articles
A/Prof. Ben Chua is a consultant Radiation Oncologist at GenesisCare Rockhampton and Brisbane (Chermside and Wesley). He qualified obtained his radiation oncology fellowship in 2015 after training in Queensland and regional New South Wales, including a fellowship in head & neck cancer. He also has an interest in complex skin, CNS and haematological malignancies. A/Prof. Chua has a conjoint appointment at the University of Queensland with an active academic portfolio, including over $2m in competitive grant funding, supervision of higher degree students, leadership of clinical trials as a chairperson and principal investigator, publications in international medical journals and presentations at international meetings.2 Articles
Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialisation of innovative therapies for the treatment of cancer and inflammatory diseases through next-generation solutions in protein homeostasis, immuno-oncology, epigenetics, immunology and neuro-inflammation.2 Articles
The leading lung cancer & mesothelioma clinical trials group in Australia & New Zealand1 Articles
Professor Martin Tattersall AO (Vale) was a true giant in Australian medical oncology. His achievements and legacy will continue to reverberate through the oncology sphere for many decades to come. He authored almost 600 papers, was a founding member of MOGA, a beloved teacher and mentor, held vital roles in myriad committees and working groups, and won multiple awards. He was also an exceptionally gifted, compassionate and kind physician who's efforts provided great comfort to patients, their families and friends. For more in-depth obituaries, see the MOGA and Cancer Council websites.1 Articles
